Gilead Sciences Inc.

NAS: GILD
Pharmaceuticals
Foster City CA
Revenue (US$ Millions)$24,890
Total Equity (US$ Millions)$15,426
Total Assets (US$ Millions)$34,664
Sales Turnover0.72
Revenues Past$11,202
Revenue Growth (%)122.20%
Return On Equity (%)106.44%
Return on Assets (%)53.79
Profit Margin (%)48.62%
Profit Growth (%)293.55
Price To Earnings Ratio14.37
Net Income (US$ Millions)$12,101
Market Capitalization (US$ Millions)$141,296
Long Term Debt (US$ Millions)$11,921
Inventory Turnover2.2
Inventories (US$ Millions)$1,386
Earnings Per Share Growth (%)306.08%
Earnings Per Share$7.35
Debt To Equity Ratio (%)0.77%
Current Liabilities (US$ Millions)$5,761
Current Assets (US$ Millions)$17,714
Cost of Goods Sold (US$ Millions)$3,788
Common Sharesout (Millions)$1,499